Trimethoxy‐Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts. Issue 11 (8th May 2013)
- Record Type:
- Journal Article
- Title:
- Trimethoxy‐Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts. Issue 11 (8th May 2013)
- Main Title:
- Trimethoxy‐Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts
- Authors:
- Dias, Steven J.
Li, Kun
Rimando, Agnes M.
Dhar, Swati
Mizuno, Cassia S.
Penman, Alan D.
Levenson, Anait S. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="pros22657-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Resveratrol (Res) is recognized as a promising cancer chemoprevention dietary polyphenol with antioxidative, anti‐inflammatory, and anticancer properties. However, the role of its analogues in prostate cancer (PCa) chemoprevention is unknown.</p> </sec> <sec id="pros22657-sec-0002" sec-type="section"> <title>METHODS</title> <p>We synthesized several natural and synthetic analogues of Res and characterized their effects on PCa cells in vitro using a cell proliferation assay. A colony formation assay and in vitro validation of luciferase (Luc) activity was done for LNCaP‐Luc cells that were consequently used for in vivo studies. The efficacy of Res, trimethoxy‐resveratrol (3M‐Res) and piceatannol (PIC) was studied in a subcutaneous (s.c.) model of PCa using oral gavage. Tumor progression was monitored by traditional caliper and bioluminescent imaging. The levels of cytokines in serum were examined by ELISA, and the levels of compounds in serum and tumor tissues were determined by gas chromatography‐mass spectrometry.</p> </sec> <sec id="pros22657-sec-0003" sec-type="section"> <title>RESULTS</title> <p>We examined the anti‐proliferative activities of Res/analogues in three PCa cell lines. We further compared the chemopreventive effects of oral Res, 3M‐Res, and PIC in LNCaP‐Luc‐xenografts. We found that 2 weeks pretreatment with the<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="pros22657-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Resveratrol (Res) is recognized as a promising cancer chemoprevention dietary polyphenol with antioxidative, anti‐inflammatory, and anticancer properties. However, the role of its analogues in prostate cancer (PCa) chemoprevention is unknown.</p> </sec> <sec id="pros22657-sec-0002" sec-type="section"> <title>METHODS</title> <p>We synthesized several natural and synthetic analogues of Res and characterized their effects on PCa cells in vitro using a cell proliferation assay. A colony formation assay and in vitro validation of luciferase (Luc) activity was done for LNCaP‐Luc cells that were consequently used for in vivo studies. The efficacy of Res, trimethoxy‐resveratrol (3M‐Res) and piceatannol (PIC) was studied in a subcutaneous (s.c.) model of PCa using oral gavage. Tumor progression was monitored by traditional caliper and bioluminescent imaging. The levels of cytokines in serum were examined by ELISA, and the levels of compounds in serum and tumor tissues were determined by gas chromatography‐mass spectrometry.</p> </sec> <sec id="pros22657-sec-0003" sec-type="section"> <title>RESULTS</title> <p>We examined the anti‐proliferative activities of Res/analogues in three PCa cell lines. We further compared the chemopreventive effects of oral Res, 3M‐Res, and PIC in LNCaP‐Luc‐xenografts. We found that 2 weeks pretreatment with the compounds diminished cell colonization, reduced tumor volume, and decreased tumor growth in the xenografts. Both 3M‐Res and PIC demonstrated higher potency in inhibiting tumor progression compared to Res. Notably, 3M‐Res was the most active in inhibiting cell proliferation and suppressing colony formation, and its accumulation in both serum and tumor tissues was the highest.</p> </sec> <sec id="pros22657-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>Our findings offer strong pre‐clinical evidence for the utilization of dietary stilbenes, particularly 3M‐Res, as novel, potent, effective chemopreventive agents in PCa. Prostate 73: 1135–1146, 2013. © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Prostate. Volume 73:Issue 11(2013)
- Journal:
- Prostate
- Issue:
- Volume 73:Issue 11(2013)
- Issue Display:
- Volume 73, Issue 11 (2013)
- Year:
- 2013
- Volume:
- 73
- Issue:
- 11
- Issue Sort Value:
- 2013-0073-0011-0000
- Page Start:
- 1135
- Page End:
- 1146
- Publication Date:
- 2013-05-08
- Subjects:
- Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.22657 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3079.xml